. . . . . . . . . . . . . "a(CHEBI:wortmannin) -| r(HGNC:RAD51)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "blocking the activations of ERK1/2 and AKT by MKK1/2 inhibitor (U0126) and phosphoinositide 3-kinase inhibitor (wortmannin) suppressed the expression of Rad51 and enhanced the erlotinib-induced cell death in erlotinib-resistant cells" . . "Selventa" . . . . "2014-07-03T14:33:36.092+02:00"^^ . . .